reglab/housing_qa huggingface dataset:
CA Health & Safety Code § 124850 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 4 - PRIMARY HEALTH CARE|CHAPTER 6 - Small and Rural Hospitals|Section 124850.

124850.  The department shall provide expert technical assistance to strategically located, high-risk rural hospitals to assist the hospitals in carrying out an assessment of potential business and diversification of service opportunities. In providing the technical assistance on business opportunities, the department shall consult with other appropriate agencies. The high-risk rural hospital, in cooperation with the department, may develop a short-term plan of action if, in its opinion, the results of the assessment so indicate. The department, in consultation with an organization of interest, shall do all of the following:(a)  Establish a process for identifying strategically located, high-risk rural hospitals and reviewing requests from the hospitals for assistance. (b)  Develop a standard format for the strategic assessment. (c)  Develop a model action plan. (d)  Establish criteria for review of action plans. (e)  Request input and assistance from organizations of interest. (f)  Make the strategic assessment format and model action plan available to all small and rural hospitals. (Amended by Stats. 2004, Ch. 225, Sec. 56. Effective August 16, 2004.)
CA Health & Safety Code § 124855 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 4 - PRIMARY HEALTH CARE|CHAPTER 6 - Small and Rural Hospitals|Section 124855.

124855.  Any small and rural hospital may apply to the California Health Facilities Financing Authority for consideration under special eligibility programs if the hospital has successfully completed the assessment and developed an action plan.(Added by Stats. 1995, Ch. 415, Sec. 8. Effective January 1, 1996.)
CA Health & Safety Code § 124860 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 4 - PRIMARY HEALTH CARE|CHAPTER 6 - Small and Rural Hospitals|Section 124860.

124860.  (a)  The department, after consultation with an organization of interest, shall select two strategically located, high-risk rural hospitals to plan and implement rural alternative hospital demonstration projects. To the extent possible, the department shall choose two demonstration sites, with one site serving an isolated mountainous area where access may be impeded by adverse weather conditions, and one site located in a rural agricultural community. Hospitals shall be selected on the basis of their interest in becoming a demonstration site and on their suitability as model rural alternative hospitals. The demonstration projects shall include, but not be limited to, identification of the following: (1)  Appropriate mix and type of services to be provided locally and obtained on referral. (2)  Types and numbers of personnel required. (3)  Probability of, and the amount of, reimbursement under current regulations. (4)  Statutory and regulatory changes necessary to license the facility and maximize reimbursement. (b)  In administering the rural alternative hospital demonstration project, the department shall do all of the following: (1)  Establish two demonstration sites on or before January 1, 1990, and operate the projects for a period of up to 18 months. (2)  Grant exceptions to the licensure requirements for general acute care hospitals that are necessary to serve the purposes of this section when the granting of the exceptions do not jeopardize the health and welfare of patients. (3)  Convey to the Federal Health Care Financing Administration its intent to establish the rural alternative hospital demonstration project and seek any necessary appropriate waivers. (4)  Consider requests for grant funds made by demonstration site hospitals pursuant to subdivision (a) of Section 1188.86 as meeting criteria for priority funding. (5)  Monitor and evaluate demonstration site projects as to the applicability of these models for statewide application. (c)  The department, based on interim findings from the demonstration projects, shall do either of the following: (1)  Prepare and adopt regulations establishing the rural alternative hospital as a licensed health facility by January 1, 1992. (2)  Submit to the Legislature by that date a report detailing why a category of health facility should not be established. (Added by Stats. 1995, Ch. 415, Sec. 8. Effective January 1, 1996.)
CA Health & Safety Code § 124865 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 4 - PRIMARY HEALTH CARE|CHAPTER 6 - Small and Rural Hospitals|Section 124865.

124865.  The department shall continue to provide regulatory relief when appropriate through program flexibility for such items as staffing, space, and physical plant requirements.(Added by Stats. 1995, Ch. 415, Sec. 8. Effective January 1, 1996.)
CA Health & Safety Code § 125300 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 5.5 - USE OF HUMAN CELLS|CHAPTER 1 - Embryo Registry|Section 125300.

125300.  The policy of the State of California shall be that research involving the derivation and use of human embryonic stem cells, human embryonic germ cells, and human adult stem cells, including somatic cell nuclear transplantation, shall be reviewed by a stem cell research oversight committee.(Amended by Stats. 2006, Ch. 483, Sec. 6. Effective January 1, 2007.)
CA Health & Safety Code § 125305 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 5.5 - USE OF HUMAN CELLS|CHAPTER 1 - Embryo Registry|Section 125305.

125305.  (a)  The department shall establish and maintain an anonymous registry of embryos that are available for research. The purpose of this registry is to provide researchers with access to embryos that are available for research purposes. (b)  The department may contract with the University of California, private organizations, or public entities to establish and administer the registry. (c)  This section shall be implemented only to the extent that funds for the purpose of establishing and administering the registry are received by the department from private or other nonstate sources. (Added by Stats. 2003, Ch. 507, Sec. 7. Effective January 1, 2004.)
CA Health & Safety Code § 125320 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 5.5 - USE OF HUMAN CELLS|CHAPTER 1 - Embryo Registry|Section 125320.

125320.  (a)  A person may not knowingly, for valuable consideration, purchase or sell embryonic or cadaveric fetal tissue for research purposes pursuant to this chapter. (b)  For purposes of this section, “valuable consideration” does not include reasonable payment for the removal, processing, disposal, preservation, quality control, storage, transplantation, or implantation of a part. (c)  Embryonic or cadaveric fetal tissue may be donated for research purposes pursuant to this chapter. (Added by renumbering Section 125117 by Stats. 2003, Ch. 507, Sec. 4. Effective January 1, 2004.)
CA Health & Safety Code § 125325 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 5.5 - USE OF HUMAN CELLS|CHAPTER 1.5 - Oocyte Retrieval For Fertility Treatment|Section 125325.

125325.  (a) The person or entity posting an advertisement seeking oocyte donation associated with the delivery of fertility treatment that includes assisted oocyte production and a financial payment or compensation of any kind, shall include the following notice in a clear and conspicuous manner: “Egg donation involves a screening process. Not all potential egg donors are selected. Not all selected egg donors receive the monetary amounts or compensation advertised. As with any medical procedure, there may be risks associated with human egg donation. Before an egg donor agrees to begin the egg donation process, and signs a legally binding contract, she is required to receive specific information on the known risks of egg donation. Consultation with your doctor prior to entering into a donor contract is advised.”(b) A summary pertaining to oocyte donation procedures, shall be provided, as required pursuant to Section 125335, to all potential egg donors before signing a legally binding contract to become an egg donor, or beginning any egg donation procedures, as part of compliance with the informed consent requirements. (c) Persons or entities that certify compliance with the American Society for Reproductive Medicine (ASRM) guidelines by registering with ASRM are exempt from the notice requirements set forth in subdivision (a). Use of the exemption when the guidelines are violated shall constitute false advertising.(d) Donors recruited through the advertisement shall undergo the same disclosure, counseling, and informed consent process, as required pursuant to Section 125335, as donors recruited by those exempt from subdivision (a).(Added by Stats. 2009, Ch. 523, Sec. 1. (AB 1317) Effective January 1, 2010.)
CA Health & Safety Code § 125325.15 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 5.5 - USE OF HUMAN CELLS|CHAPTER 1.5 - Oocyte Retrieval For Fertility Treatment|Section 125325.15.

125325.15.  The following definitions shall apply to this chapter:(a) “Assisted oocyte production” or “AOP” means surgical extraction of oocytes following pharmaceutically induced manipulation of oocyte production through the use of ovarian stimulation for the purposes of fertility treatment.(b) “Oocyte” means a female egg or egg cell of a human female.(Added by Stats. 2009, Ch. 523, Sec. 1. (AB 1317) Effective January 1, 2010.)
CA Health & Safety Code § 125330 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 5.5 - USE OF HUMAN CELLS|CHAPTER 2 - Procuring of Oocytes for Research|Section 125330.

125330.  The following definitions apply to this chapter:(a) “Alternate method of oocyte retrieval” means a method of oocyte retrieval that does not involve the pharmaceutically induced manipulation of oocyte production.(b) “Assisted oocyte production” or “AOP” means surgical extraction of oocytes following pharmaceutically induced manipulation of oocyte production through the use of ovarian stimulation.(c) “Informed consent” means a research participant understands the material facts reasonably necessary to make a determination to participate or to refuse from participating in the medical research without the intervention of any element of force, fraud, deceit, duress, coercion, or undue influence on the research participant’s decision.(d) “Institutional review board” means a body established in accordance with federal regulations, including Part 46 (commencing with Section 46.101) of Subchapter A of Subtitle A of Title 45 of the Code of Federal Regulations.(e) “Oocyte” means a female egg or egg cell of a human female.(f) “Research participant” means any person undergoing AOP or any alternative method of ovarian retrieval for research or for the development of medical therapies, including those who would not meet the definition of “subject” under 45 C.F.R. 46.102. The protections afforded to human subjects under an institutional review board apply to research participants in this chapter.(Amended by Stats. 2019, Ch. 864, Sec. 2. (AB 922) Effective January 1, 2020.)
CA Health & Safety Code § 125331 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 5.5 - USE OF HUMAN CELLS|CHAPTER 2 - Procuring of Oocytes for Research|Section 125331.

125331.  (a) As used in this chapter, “Research Participants Undergoing Oocyte Retrieval for Medical Research Purposes Bill of Rights” means a list of the rights of a research participant providing human oocytes for the purposes of medical research. The list of rights shall be written in a language in which the research participant is fluent. The list shall incorporate all the rights and protections in this chapter, and include, but not be limited to, all of the following research participant rights as described in Section 24172:(1) The right to be informed of the nature and purpose of the medical research.(2) The right to be given an explanation of the procedures to be followed in the medical research, and any drug or device to be utilized.(3) The right to be given a description of any attendant discomforts and reasonably foreseeable risks expected from participating in the medical research.(4) The right to be given an explanation of any benefits to the research participant reasonably to be expected from the medical research, if applicable.(5) The right to be given a disclosure of any appropriate alternative procedures, drugs, or devices that might be advantageous to the research participant, and their relative risks and benefits.(6) The right to be informed of the avenues of medical treatment, if any, available to the research participant after the medical research if complications should arise.(7) The right to be given an opportunity to ask any questions concerning the experiment or the procedures involved.(8) The right to be instructed that consent to participate in the medical research may be withdrawn at any time and the research participant may discontinue participation in the medical research without prejudice.(9) The right to be given a copy of the signed and dated written consent form as provided for by Section 24173 or Section 24178.(10) The right to be given the opportunity to decide to consent or not to consent to a medical experiment without the intervention of any element of force, fraud, deceit, duress, coercion, or undue influence on the research participant’s decision. (b) The rights provided by this section do not supersede, but are in addition to, the rights afforded a research participant pursuant to the Protection of Human Subjects in Medical Experimentation Act (Chapter 1.3 (commencing with Section 24170) of Division 20).(Added by Stats. 2019, Ch. 864, Sec. 3. (AB 922) Effective January 1, 2020.)
CA Health & Safety Code § 125335 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 5.5 - USE OF HUMAN CELLS|CHAPTER 2 - Procuring of Oocytes for Research|Section 125335.

125335.  (a) Prior to obtaining informed consent from a subject for AOP or any alternative method of ovarian retrieval on a subject for the purpose of procuring oocytes for research or the development of medical therapies, a physician and surgeon shall provide to the subject a standardized medically accurate written summary of health and consumer issues associated with AOP and any alternative methods of oocyte retrieval. The failure to provide to a subject this standardized medically accurate written summary constitutes unprofessional conduct within the meaning of Chapter 5 (commencing with Section 2000) of Division 2 of the Business and Professions Code.(b) The summary shall include, but not be limited to, medically accurate disclosures concerning the potential risks of AOP or any alternative method of oocyte retrieval, including the risks associated with the surgical procedure and with using the drugs, medications, and hormones prescribed for ovarian stimulation during the AOP process or any alternative method of oocyte retrieval.(c) For purposes of subdivision (a), “written summary of health and consumer issues” means the guide published and updated by the American Society for Reproductive Medicine entitled, “Assisted Reproductive Technology: A Guide for Patients” or an alternative written medically accurate document prepared by a recognized authority on oocyte retrieval for medical research that also meets the criteria included in this section. This alternative document may be one that has been approved and recommended by the State Department of Public Health pursuant to Section 125118 and shall include all of the following:(1) The document shall adhere to simplified reading standards, including, but not limited to, those generally accepted and required for government publications. The document shall be written in layperson’s language and shall be made available in languages spoken by subjects in the study if their proficiency is largely in a language other than English. All information in the document shall be conveyed to the subject orally in easy to understand and nontechnical terms.(2) The document shall include additional resources for, or list additional sources of, medical information on health and safety issues surrounding oocyte retrieval.(Amended by Stats. 2007, Ch. 483, Sec. 34. Effective January 1, 2008.)
CA Health & Safety Code § 125340 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 5.5 - USE OF HUMAN CELLS|CHAPTER 2 - Procuring of Oocytes for Research|Section 125340.

125340.  (a) Prior to providing AOP or any alternative method of ovarian retrieval to a research participant for the purposes of medical research or development of medical therapies, a physician and surgeon shall obtain written and oral informed consent for the procedure from the research participant. Informed consent for the purposes of this chapter shall include a signed acknowledgment of the rights contained in the Research Participants Undergoing Oocyte Retrieval for Medical Research Purposes Bill of Rights and comply with the informed consent requirements of the Protection of Human Subjects in Medical Experimentation Act (Chapter 1.3 (commencing with Section 24170) of Division 20).(b) The failure to obtain written informed consent from the research participant constitutes unprofessional conduct within the meaning of Chapter 5 (commencing with Section 2000) of Division 2 of the Business and Professions Code. This section does not relieve the physician and surgeon from other existing duties under the law, including, but not limited to, the duty to obtain a research participant’s informed consent after fully explaining the proposed procedure. The requirement that a physician and surgeon provide the standardized written summary pursuant to Section 125335 is in addition to, and does not supplant, other existing legal requirements regarding informed consent, including, but not limited to, compliance with the Protection of Human Subjects in Medical Experimentation Act (Chapter 1.3 (commencing with Section 24170) of Division 20).(c) This chapter does not affect the suitability or availability of oocytes procured for research before January 1, 2007, if the oocytes were donated pursuant to protocols or standards that are generally recognized and accepted by national or international scientific bodies.(d) A written document required pursuant to this section shall adhere to simplified reading standards, including, but not limited to, those generally accepted and required for government publications, and in layperson’s language. The document shall be made available in languages spoken by research participants in the study if their proficiency is largely in a language other than English. All information in the written informed consent document shall also be conveyed to the research participant orally in easy to understand and nontechnical terms.(e) Research conducted pursuant to this chapter shall adhere to federal regulations governing informed consent pursuant to Section 46.116 of Title 45 of the Code of Federal Regulations.(f) This section does not limit or expand the right of an injured research participant to recover damages under any applicable law.(Amended by Stats. 2019, Ch. 864, Sec. 4. (AB 922) Effective January 1, 2020.)
CA Health & Safety Code § 125342 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 106 - PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT)|PART 5.5 - USE OF HUMAN CELLS|CHAPTER 2 - Procuring of Oocytes for Research|Section 125342.

125342.  (a) A research program or project that involves AOP or any alternative method of oocyte retrieval shall ensure that a written record is established and maintained to include, but not be limited to, all of the following components:(1) The demographics of subjects, including, but not limited to, their age, race, primary language, ethnicity, income bracket, education level, and the first three digits of the ZIP Code of current residence.(2) Information regarding every oocyte that has been donated or used. This record should be sufficient to determine the provenance and disposition of those materials.(3) A record of all adverse health outcomes, including, but not limited to, incidences and degrees of severity, resulting from the AOP or any alternative method of oocyte retrieval.(b) (1) The information included in the written record pursuant to subdivision (a) shall not disclose personally identifiable information about subjects, and shall be confidential and is deemed protected by subject privacy provisions of law. This information shall be reported to the State Department of Public Health, which shall aggregate the data and make it publicly available, as set forth in paragraph (2), in a manner that does not reveal personally identifiable information about the subjects.(2) The department shall provide public access to information which it is required to release pursuant to the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code). The department shall disseminate the information to the general public via governmental and other Web sites in a manner that is understandable to the average person. The information shall be made available to the public when the biennial review pursuant to Section 125119.5 is provided to the Legislature.(Amended by Stats. 2007, Ch. 483, Sec. 35. Effective January 1, 2008. Superseded on January 1, 2023; see amendment by Stats. 2021, Ch. 615.)